Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly MLL gene rearrangement. (A molecular abnormality indicating rearrangement of the MLL (KMT2A) gene.)
Biomarker and diagnostic research for acute myeloid leukemia, MLL gene rearrangement has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, MLL gene rearrangement.
139 publications have been identified in PubMed for acute myeloid leukemia, MLL gene rearrangement. Research spans Review / Meta-Analysis (29%), Basic Science / Preclinical (27%), and Gene Therapy / Novel Therapeutics (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 40 | 29% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:52 AM UTC
Common questions about acute myeloid leukemia, MLL gene rearrangement
Laboratory research
37 |
27% |
New treatment approaches | 15 | 11% |
Testing and diagnosis research | 11 | 8% |
Patient case studies | 11 | 8% |
Clinical study results | 11 | 8% |
Disease patterns and progression | 11 | 8% |
Other research | 3 | 2% |
Zhang Y (2026). [PMID: 41368921](https://pubmed.ncbi.nlm.nih.gov/41368921/). *Hematology*. [Review / Meta-Analysis]
Schäfer S (2026). [PMID: 41712378](https://pubmed.ncbi.nlm.nih.gov/41712378/). *Cell Rep*. [Clinical Trial Publication]
Shoji K (2026). [PMID: 41126738](https://pubmed.ncbi.nlm.nih.gov/41126738/). *Haematologica*. [Diagnostic / Biomarker]
Palau A (2026). [PMID: 41438598](https://pubmed.ncbi.nlm.nih.gov/41438598/). *Blood Neoplasia*. [Basic Science / Preclinical]
Mendoza-Castrejon J (2026). [PMID: 41032751](https://pubmed.ncbi.nlm.nih.gov/41032751/). *Blood*. [Basic Science / Preclinical]
Wang Z (2026). [PMID: 41611280](https://pubmed.ncbi.nlm.nih.gov/41611280/). *Zhonghua Yi Xue Za Zhi*. [Basic Science / Preclinical]
Wei AH (2026). [PMID: 41105915](https://pubmed.ncbi.nlm.nih.gov/41105915/). *Blood*. [Gene Therapy / Novel Therapeutics]
Fetsch V (2026). [PMID: 41144759](https://pubmed.ncbi.nlm.nih.gov/41144759/). *Blood*. [Epidemiology / Natural History]
Camiolo G (2026). [PMID: 41545699](https://pubmed.ncbi.nlm.nih.gov/41545699/). *Leukemia*. [Basic Science / Preclinical]
Perner F (2026). [PMID: 39887730](https://pubmed.ncbi.nlm.nih.gov/39887730/). *Int J Cancer*. [Review / Meta-Analysis]